Evidence map›Paper›PMID 17311013›Full record

ReviewBritish journal of cancer2007

Cellular senescence and chromatin organisation.

M Narita

Abstract readReview
In one paragraph

Review in British journal of cancer, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Bcl-xL as a Modulator of Senescence and Aging.International journal of molecular sciences · 2021
    Review
  15. Review
  16. HMGA Genes and Proteins in Development and Evolution.International journal of molecular sciences · 2020
    Review
  17. Article
  18. The Role of p16International journal of molecular sciences · 2017
    Review
  19. Dissecting cellular senescence and SASP inInflammation and regeneration · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

M NaritaCancer Research UK, Cambridge Research Institute, Robinson Way, Cambridge, UK. masashi.narita@cancer.org.uk

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the potential importance of senescence in tumour suppression, its effector mechanism is poorly understood. Recent studies suggest that alterations in the chromatin environment might add an additional layer of stability to the phenotype. In this review, recent discoveries on the interplay between senescence and chromatin biology are overviewed.

Indexed as

AnimalsCellular SenescenceChromatinEpigenesis, GeneticHumansNeoplasmsChromatin

Identifiers

PMID17311013
PMCPMC2360064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.